CD79A and nasopharyngeal carcinoma: Among those biomarkers, VCA‐IgA exhibits high sensitivity and specificity for the diagnosis of NPC, whereas VCA‐IgA was undetectable in 4–24% of NPC patients, which might result in misdiagnosis (Chan et al, 2003).